U-MTEM

Q:MTEM - MOLECULAR TEMPLATES INC - https://www.mtem.com

01:20:47 EDT

Sym-X	Bid - Ask					Last	Chg	%Ch	Vol	$Vol	#Tr	Open-Hi-Lo	Year Hi-Lo	Last Tr	News	Delay
MTEM - Q	5.0	0.35	·	0.46	1.0	0.48	+0.0027	0.6	65.7	24	149	0.50 0.50 0.4735	1.23 0.31	19:30:36	Jun 01	15 min RT 2¢

Trade times are ET. News times are ET. Bid/ask/vol sizes in thousands.
Nasdaq Indicators -- Market: Nasdaq -- Bid Tick: Down -- UPC Restricted: No

Fundamentals · Holders · Trade Workstation · Market Depth · 3 Month Closes · Technical Charts 1 yr | 2 yr | 3 yr | 5 yr | 10 yr | 15 yr | 20 yr · Live Charts 1 yr | 1 day · 1yr Bulletins · Historical · Options · Portfolio

Recent Trades - Last 10 of 149

More trades...

Time ET	Ex	Price	Change	Volume
19:30:36	Q	0.4402	-0.0519	1
19:07:18	Q	0.46	-0.0321	1,000
18:35:53	Q	0.46	-0.0321	100
18:35:53	Q	0.46	-0.0321	300
18:23:46	Q	0.46	-0.0321	37
17:25:14	Q	0.4599	-0.0322	200
17:00:36	Q	0.46	-0.0321	900
17:00:36	Q	0.46	-0.0321	100
16:46:56	Q	0.46	-0.0321	1,000
16:37:03	Q	0.46	-0.0321	1

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Date ET	Symbol	Type	Headline
2023-06-01 07:57	U:MTEM	News Release200	Molecular Templates Announces the FDA Removal of Partial Clinical Hold in the Phase 1 Clinical Trial for MT-0169 and Focuses on Extramedullary Myeloma
2023-05-26 17:10	U:MTEM	News Release200	Molecular Templates to Present on Phase I Dose Escalation Study of MT-6402 at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting
2023-05-15 16:13	U:MTEM	News Release200	Molecular Templates, Inc. Reports First Quarter 2023 Financial Results and Business Update

Date ET

Symbol

Type

Headline

2023-06-01 07:57

U:MTEM

News Release

Molecular Templates Announces the FDA Removal of Partial Clinical Hold in the Phase 1 Clinical Trial for MT-0169 and Focuses on Extramedullary Myeloma

2023-05-26 17:10

U:MTEM

News Release

Molecular Templates to Present on Phase I Dose Escalation Study of MT-6402 at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting

2023-05-15 16:13

U:MTEM

News Release

Molecular Templates, Inc. Reports First Quarter 2023 Financial Results and Business Update